Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-324991
Filing Date
2025-12-18
Accepted
2025-12-18 16:50:03
Documents
1
Period of Report
2025-12-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3982
  Complete submission text file 0001193125-25-324991.txt   5513
Mailing Address 138 THISTLE ROAD NORTH ANDOVER MA 08145
Business Address
Lucera Erick (Reporting) CIK: 0001697616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251583722

Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)